highly significantP < 0.001
Most notably, patients with malignant thyroid tumors had dramatically reduced VAP-1 concentrations (347.99 ± 4.29 pg/mL), with differences being highly significant across all comparisons (P < 0.001) Table 5 .
Most notably, patients with malignant thyroid tumors had dramatically reduced VAP-1 concentrations (347.99 ± 4.29 pg/mL), with differences being highly significant across all comparisons (P < 0.001) Table 5 .
Notably, the difference in TSH between benign and malignant patients did not reach statistical significance (P = 0.3) Table 2 .